You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 33 No. 1, January 1976 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Lithium Carbonate and Affective Disorders

V: A Double-Blind Study of Prophylaxis of Depression in Bipolar Illness

David L. Dunner, MD; Frank Stallone, PhD; Ronald R. Fieve, MD

Arch Gen Psychiatry. 1976;33(1):117-120.


Abstract

• The efficacy of lithium carbonate as a prophylactic drug against depression in bipolar manic depressive patients was assessed through a double-blind, placebo-controlled study of patients who had histories of recurrent depressions and hypomanias ("bipolar II"). The results revealed that treatment with lithium carbonate resulted in a reduction in the frequency of hypomanic episodes. However, no reduction in the frequency of depressive attacks was observed with lithium carbonate treatment during the study (mean length of study, approximately 16 months), although there was a suggestion that the depressive attacks that occurred during treatment with lithium carbonate might be less severe than with placebo treatment.



Author Affiliations

From the Department of Internal Medicine, New York State Psychiatric Institute, New York.


Footnotes

Accepted for publication April 24, 1975.

Reprint requests to Department of Internal Medicine, New York State Psychiatric Institute, 722 W 168th St, New York, NY 10032 (Dr Dunner).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Pharmacological interventions for the prevention of relapse in bipolar disorder: a systematic review of controlled trials
Beynon et al.
J Psychopharmacol 2009;23:574-591.
ABSTRACT  

What Is a "Mood Stabilizer"? An Evidence-Based Response
Bauer and Mitchner
Am. J. Psychiatry 2004;161:3-18.
ABSTRACT | FULL TEXT  

A Placebo-Controlled 18-Month Trial of Lamotrigine and Lithium Maintenance Treatment in Recently Manic or Hypomanic Patients With Bipolar I Disorder
Bowden et al.
Arch Gen Psychiatry 2003;60:392-400.
ABSTRACT | FULL TEXT  

Practice Guideline for the Treatment of Patients With Bipolar Disorder (Revision)
Hirschfeld et al.
Focus 2003;1:64-110.
FULL TEXT  

Use of Antidepressants to Treat Depression in Bipolar Disorder
El-Mallakh and Karippot
Psychiatr. Serv. 2002;53:580-584.
ABSTRACT | FULL TEXT  

Pharmacologic Treatment of Bipolar Disorder Through the Life Cycle
Jackson
Journal of Pharmacy Practice 1996;9:95-103.
ABSTRACT  

The Differential Diagnosis of Depression: Relevance of Positron Emission Tomography Studies of Cerebral Glucose Metabolism to the Bipolar-Unipolar Dichotomy
Schwartz et al.
JAMA 1987;258:1368-1374.
ABSTRACT  

Lithium Carbonate and Imipramine in the Prophylaxis of Unipolar and Bipolar II Illness: A Prospective, Placebo-Controlled Comparison
Kane et al.
Arch Gen Psychiatry 1982;39:1065-1069.
ABSTRACT  

Prediction of Treatment Response in Mania
Taylor and Abrams
Arch Gen Psychiatry 1981;38:800-803.
ABSTRACT  

Prediction of Treatment Outcome With Lithium
Carroll
Arch Gen Psychiatry 1979;36:870-878.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1976 American Medical Association. All Rights Reserved.